Manuel Aivado

4.9k citations

89 papers · 3.3k indexed · h-index 31

Impact in

Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Hematopoietic Stem Cell Transplantation
Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 54
- Acute Myeloid Leukemia Research 28
- Platelet Disorders and Treatments 19
- Hematopoietic Stem Cell Transplantation 10
Genetics 26
- Chronic Lymphocytic Leukemia Research 16
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10

Co-authors: Ulrich Germing Norbert Gattermann Corinna Strupp Rainer Haas Barbara Hildebrandt Mansoor N. Saleh James B. Bussel Gregory Cheng
Journals: Blood (23 papers)Annals of Oncology (5 papers)European Journal Of Haematology (5 papers)British Journal of Haematology (4 papers)Leukemia Research (4 papers)
Partner nations: United States Germany Hong Kong

In The Last Decade

Manuel Aivado

87 papers receiving 3.3k citations

Peers

Countries citing papers authored by Manuel Aivado

Since Specialization

Citations

This map shows the geographic impact of Manuel Aivado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Aivado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Aivado more than expected).

Fields of papers citing papers by Manuel Aivado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Aivado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Aivado. The network helps show where Manuel Aivado may publish in the future.

Co-authors

The 25 scholars most cited alongside Manuel Aivado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manuel Aivado Line = papers co-authored together Manuel Aivado links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	LB1018 ALRN-6924, a dual inhibitor of MDMX and MDM2, protects human scalp hair follicles and their epithelial stem cells from paclitaxel-induced toxicity Journal of Investigative Dermatology ·Jennifer Gherardini, Davey Smith, Jérémy Chéret, Manuel Aivado, Ralf Paus	2022	1
2	Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity Cancer Discovery ·Xiaolei Zhou, Madhurendra Singh, Gema Sanz, Vincent Guerlavais, Luis A. Carvajal, Manuel Aivado, Yue Zhan, Mariana M.S. Oliveira, Lisa S. Westerberg, D. Allen Annis, John Inge Johnsen, Galina Selivanova	2021	113
3	Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53 Clinical Cancer Research ·Mansoor N. Saleh, Manish R. Patel, Todd M. Bauer, Sanjay Goel, Gerald S. Falchook, Geoffrey I. Shapiro, Ki Y. Chung, Jeffrey R. Infante, Robert M. Conry, Guilherme Rabinowits, David S. Hong, Judy S. Wang, Ulrich Steidl, Gurudatta Naik, Vincent Guerlavais, Vojislav Vukovic, D. Allen Annis, Manuel Aivado, Funda Meric‐Bernstam	2021	110
4	Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome Blood ·Britta Will, Masahiro Kawahara, Hui Lei, Ingmar Bruns, Samir Parekh, Connie L. Erickson‐Miller, Manuel Aivado, Amit Verma, Ulrich Steidl	2009	95
5	A phase III, double-blind, placebo-controlled study (RAISE) of eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura (ITP) Journal of Thrombosis and Haemostasis ·Gang Cheng, F.G. Kondev, JB Bussel, Claus Werenberg Marcher, Sandra Y. Vasey, Bryan T. Mayer, Manuel Aivado, M. Arning, Jianqing Bu	2009	2
6	Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function Experimental Hematology ·Joseph A. Erhardt, Connie L. Erickson‐Miller, Manuel Aivado, Xuchen Song, Kodandaram Pillarisetti, John R. Toomey	2009	69
7	EFFICACY AND SAFETY OF REPEATED INTERMITTENT TREATMENT WITH ELTROMBOPAG IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) Bethan Psaila, J B Bussel, Sandra Y. Vasey, Manuel Aivado, Beate Mayer, Nicole L. Stone, M. Arning	2008	2
8	Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDS British Journal of Haematology ·Akos Czibere, Wolf Christian Prall, Luiz F. Zerbini, Markus Jäger, Guido Kobbe, Sabine Knipp, Towia A. Libermann, Rainer Haas, Manuel Aivado	2006	11
9	Perspectives of proteomics in acute myeloid leukemia Expert Review of Anticancer Therapy ·Akos Czibere, Franck Grall, Manuel Aivado	2006	9
10	Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin’s lymphoma Annals of Hematology ·Frank Neumann, Cristiano G. França, Simona Martin, Ralf Kronenwett, Mustafa Kondakci, Manuel Aivado, Ulrich Germing, 正裕立野, Guido Kobbe	2006	18
11	Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells Nature Genetics ·Ulrich Steidl, Frank Rosenbauer, Roel G.W. Verhaak, Xuesong Gu, Alexander K. Ebralidze, Hasan H. Otu, Steffen Klippel, Christian Steidl, Ingmar Bruns, Daniel B. Costa, Katharina Wagner, Manuel Aivado, Guido Kobbe, Peter J.M. Valk, Emmanuelle Passegué, Towia A. Libermann, Ruud Delwel, Daniel G. Tenen	2006	132
12	The ratio between CD4 + and CD8 + cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomide Leukemia & lymphoma ·Corinna Strupp, Ulrich Germing, Manuel Aivado, Andrea Kündgen, Roland Fenk, マノハル L サリン, Guido Kobbe, Rainer Haas, Norbert Gattermann	2005	4
13	Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling Clinical Chemistry and Laboratory Medicine (CCLM) ·Manuel Aivado, Dimitrios Spentzos, Gil Alterovitz, Hasan H. Otu, Franck Grall, Aristoteles Giagounidis, Meghan Wells, Je‐Yoel Cho, Ulrich Germing, Akos Czibere, Wolf Christian Prall, Christopher J. H. Porter, Marco Ramoni, Towia A. Libermann	2005	40
14	Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals British Journal of Haematology ·Ulrich Germing, Corinna Strupp, Andrea Kuendgen, Manuel Aivado, Aristoteles Giagounidis, Barbara Hildebrandt, Carlo Aul, Rainer Haas, Norbert Gattermann	2005	15
15	Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31–q33 with a combination of all-trans-retinoic acid and tocopherol-α: a phase II study Annals of Hematology ·Aristoteles Giagounidis, Sabine Haase, Ulrich Germing, Brigitte Schlegelberger, Ludwig Wilkens, Sammantha B. Lane, Hans Kreipe, Muhammad Ilham Aldika Akbar, FJ Rescorla, Matheus de Rocha, Frank Rothmann, Michael Lübbert, Arnold Ganser, Manuel Aivado, Michael Heinsch, Carlo Aul	2005	18
16	Quantitative real‐time reverse‐transcription polymerase chain reaction for diagnosis of BCR‐ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation European Journal Of Haematology ·Frank Neumann, 礼太大塚, Barbara Hildebrandt, Guido Kobbe, Manuel Aivado, Surat Sriworawit, L.C. Albarracin Calderon, Anatoliy Bosenko, Roland Fenk, P. Schneider, Norbert Gattermann, Brigitte Royer‐Pokora, Rainer Haas, Ralf Kronenwett	2003	29
17	Angioimmunoblastic Lymphadenopathy (AILD) May Respond to Thalidomide Treatment: Two Case Reports Leukemia & lymphoma ·Corinna Strupp, Manuel Aivado, Ulrich Germing, Norbert Gattermann, Rainer Haas	2002	34
18	Are AClonal@ X-chromosome inactivation patterns of T cells in MDS dependent on disease duration ? Evaluation of 117 patients with MDS Blood ·Andrea Kündgen, Manuel Aivado, S. Kusama, Johannes van Dijk, Michel Delforge, Chul Jun Seok, M Jotterand-Bellomo, Isabelle Tigaud, Aristoteles Giagounidis, David Solorio, Cristiane dos Santos Parnaiba, N. W Goodman, R. Haas, 李永山, F Souki-Chmeit	2001	1
19	Analysis of clonality by HUMARA PCR in high risk MDS patients before and after intensive anti-leukemic treatment Blood ·Johannes van Dijk, Manuel Aivado, Michel Delforge, Robert J. van Soest, Gianfranco Catalano, B. Johansson, Isabelle Tigaud, M Jotterand-Bellomo, Jaroslav Čermák, Chul Jun Seok, Stefan Suciu, Bert van der Reijden, Joop H. Jansen, Petra Muus, T. de Witte	2001	1
20	Long‐term remission after intensive chemotherapy in advanced myelodysplastic syndromes is generally associated with restoration of polyclonal haemopoiesis British Journal of Haematology ·Manuel Aivado, Surat Sriworawit, Ulrich Germing, Norbert Gattermann, Guido Kobbe, Antonio Orozco Villar, 正裕立野, Hongyi Lin	2000	19

About Manuel Aivado

Manuel Aivado is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 89 papers that have together received 3.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (28 papers), Platelet Disorders and Treatments (19 papers), Chronic Lymphocytic Leukemia Research (16 papers), Cancer-related Molecular Pathways (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Hematopoietic Stem Cell Transplantation (10 papers), Advanced Breast Cancer Therapies (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Hematology (2.1k citations), Genetics (843 citations), Pathology and Forensic Medicine (398 citations), Oncology (508 citations) and Molecular Biology (1.2k citations). Manuel Aivado has collaborated with scholars based in United States, Germany and Hong Kong. Frequent co-authors include Ulrich Germing, Norbert Gattermann, Corinna Strupp, Rainer Haas, Barbara Hildebrandt, Mansoor N. Saleh, James B. Bussel, Gregory Cheng, Nicole L. Stone and Bhabita Mayer. Their work appears in journals such as Blood, Annals of Oncology, European Journal Of Haematology, British Journal of Haematology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact